DREAMM-7 STUDY OF BELANTAMAB MAFODOTIN + BORTEZOMIB + DEXAMETHASONE VS DARATUMUMAB + BORTEZOMIB + DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY IN PATIENTS BY SUBSEQUENT THERAPY

EHA Library, Vania Hungria, 4160809

IMPACT OF PLASMA CELL QUANTIFICATION METHODS ON IMWG DIAGNOSTIC CRITERIA: A COMPARATIVE STUDY USING WHOLE-SLIDE IMAGING BY QUPATH ON BONE MARROW SMEARS, CD138-IMMUNOSTAINED CLOTS, AND BIOPSIES IN MGUS AND SMM DIAGNOSIS

EHA Library, Atsushi Uehara, 4160810

TALQUETAMAB VS REAL-WORLD PHYSICIAN'S CHOICE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN THERAPY: UPDATED ANALYSES OF MONUMENTAL-1 VS LOCOMMOTION/MOMMENT

EHA Library, María-Victoria Mateos, 4160811

UPDATED COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN'S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Hermann Einsele, 4160812

RETROSPECTIVE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN EUROPEAN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA NOT RECEIVING STEM CELL TRANSPLANTATION

EHA Library, Mamta Garg, 4160813

SECOND PRIMARY MALIGNANCY IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA IN SWEDEN 2008-2017: RESULTS FROM A POPULATION-BASED STUDY

EHA Library, Ingigerdur Sverrisdottir, 4160814

OM336, A B CELL MATURATION ANTIGEN (BCMA) TARGETING T CELL ENGAGER ANTIBODY, DEMONSTRATES INITIAL SAFETY AND EFFICACY IN THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (R/R MM)

EHA Library, Charlie Zhou, 4160815

REAL-WORLD EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN (BELAMAF) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED IN EUROPE

EHA Library, Michele Cavo, 4160816

CYSTATIN C AS BIOMARKER FOR THE EVALUATION OF THE EVALUATION OF RENAL OUTCOME IN RENAL AL AMYLOIDOSIS

EHA Library, Foteini Theodorakakou, 4160817

POMALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE (PVD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) IN NDMM PATIENTS WITH RENAL INJURY(RI): A MULTICENTER, RANDOMIZED CONTROLLED, OPEN-LABEL TRIAL

EHA Library, Jin Lu, 4160818

THE PHASE I/II TG01-STUDY - VACCINATING AGAINST RAS-MUTATED MULTIPLE MYELOMA

EHA Library, Hanne Marie Liddle Norseth, 4160819

CLINICAL UNMET NEED OF LENALIDOMIDE-REFRACTORY VS NON-LENALIDOMIDE-REFRACTORY PATIENTS WITH MULTIPLE MYELOMA IN THE HONEUR FEDERATED DATA NETWORK

EHA Library, Roman Hájek, 4160820

MULTICENTER PHASE 2 STUDY OF SUBCUTANEOUS ISATUXIMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA SC-VRD) IN NEWLY DIAGNOSED TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA (NDMM TI): RESULTS FROM ISASOCUT (IFM 2022-05)

EHA Library, Arthur Bobin, 4160821

REAL-WORLD REASSESSMENT OF PROPOSED CLINICAL TRIAL CRITERIA AND TRANSLATIONAL FEATURES IN HIGH-RISK SMOLDERING MULTIPLE MYELOMA

EHA Library, Sven Krippner, 4160822

INCREASED RISK OF INFECTIONS IN INDIVIDUALS WITH SMOLDERING MULTIPLE MYELOMA: RESULTS FROM THE SCREENED ISTOPMM STUDY

EHA Library, Lærke Sloth Andersen, 4160823

CARFILZOMIB AND LENALIDOMIDE FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: LONG-TERM FOLLOW-UP OF THE EMN12/HOVON-129 STUDY

EHA Library, Niels W C J van de Donk, 4160824

CARFILZOMIB-POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MYELOMA IN THE ERA OF QUADRUPLET THERAPY : A MULTICENTER REAL-WORLD STUDY

EHA Library, Pierre-Edouard Debureaux, 4160825

DIFFERENCES ACROSS COUNTRIES IN HEALTHCARE PROVIDER CONFIDENCE WITH CAR-T AND BISPECIFIC ANTIBODY THERAPIES FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Elena Zamagni, 4160826

CLINICAL MANAGEMENT OF BELANTAMAB MAFODOTIN-ASSOCIATED OCULAR EVENTS: PRACTICAL GUIDANCE FROM THE BELAMAF EXPERT EXPERIENCE PROGRAM

EHA Library, Evangelos Terpos, 4160827

COMPARATIVE ANALYSIS OF TREATMENT PATTERNS AND OUTCOMES IN 2,202 OCTOGENARIANS VS. 5,823 ELDERLY PATIENTS (70-

EHA Library, Irit Avivi Mazza, 4160828

THE IMPACT OF CHROMOSOME 1Q21 ABNORMALITIES ON FRONTLINE TREATMENT OUTCOMES IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: INSIGHTS FROM A MULTICENTER RETROSPECTIVE COHORT STUDY

EHA Library, Jian Cui, 4160829

CHARACTERIZING REAL-WORLD TREATMENT UTILIZATION AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) AFTER LENALIDOMIDE AND ANTI-CD38 EXPOSURE IN THE UNITED STATES

EHA Library, Andrew J. Cowan, 4160830

A SINGLE-ARM, MULTI-CENTER, OBSERVATIONAL CLINICAL STUDY OF SELINEXOR COMBINED BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE REGIMEN FOR NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM) WITH HIGH-RISK FACTORS

EHA Library, Yuping Zhong, 4160831

DEVELOPMENT OF A RISK STRATIFICATION ALGORITHM IN TRIPLE-CLASS EXPOSED (TCE) AND DOUBLE-CLASS EXPOSED (DCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) USING THE FLATIRON HEALTH DATABASE

EHA Library, Michel Delforge, 4160832

DIFFERENCES IN INCIDENCE OF CYTOKINE RELEASE SYNDROME (CRS) AND IMPACT ON OVERALL SURVIVAL (OS) IN MULTIPLE MYELOMA PATIENTS TREATED WITH ANTI-BCMA VS. ANTI-GCPR5D BISPECIFIC ANTIBODIES: A REAL-WORLD ANALYSIS

EHA Library, Heidi Cho, 4160833

SOLUBLE SERUM FASL (SFASL) LEVELS IN MULTIPLE MYELOMA (MM) PATIENTS.

EHA Library, George Oikonomou, 4160834

PROPHYLACTIC TOCILIZUMAB TO MITIGATE CYTOKINE RELEASE SYNDROME AND OUTPATIENT DOSING OF TALQUETAMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1/2 MONUMENTAL-1 RESULTS

EHA Library, Dominik Dytfeld, 4160835

CHARACTERIZATION OF OPHTHALMIC EXAMINATION FINDINGS (OEFS) AND IMPACT ON READING AND DRIVING IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF)

EHA Library, Roman Hájek, 4160836

CHARACTERIZATION OF INFECTIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF)-BASED REGIMENS FROM DREAMM-7 AND DREAMM-8 TRIALS

EHA Library, Pawel Robak, 4160837

HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRANSPLANT-INELIGIBLE OR TRANSPLANT-DEFERRED NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) IN THE PHASE 3 CEPHEUS TRIAL

EHA Library, Vania Hungria, 4160838

OUTPATIENT STEP-UP DOSING AND SAFETY WITH TALQUETAMAB: A REAL-WORLD MAYO CLINIC STUDY

EHA Library, Shaji Kumar, 4160839

PROGNOSTIC IMPACT OF DYNAMIC CHANGES OF TYPE I MELANOMA ANTIGEN GENE PROTEINS CT7 (MAGE-C1/CT7) TRANSCRIPTS IN MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS

EHA Library, Jin Lu, 4160840

REAL-WORLD ANALYSIS OF TALQUETAMAB IN HEAVILY PRETREATED AND HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Carlyn Rose Tan, 4160841

ADVANCED RISK PREDICTION FOR SMOLDERING MULTIPLE MYELOMA (SMM) PATIENTS THROUGH THE COMBINATION OF MAYO CLINIC'S 2/20/20 MODEL WITH TELOVIEW SMM RISK ASSESSMENT.

EHA Library, Shaji Kumar, 4160842

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH TWO TO FOUR LINES OF TREATMENT IN THE PREAMBLE REGISTRY

EHA Library, Claudio Cerchione, 4160843

EVALUATION OF A NOVEL PATIENT-REPORTED TOOL GUIDING EXTENDED DOSING SCHEDULE OF BELANTAMAB MAFODOTIN IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; UPDATED OPHTHALMIC SAFETY FROM A PHASE 1/2 TRIAL OF THE GREEK MYELOMA STUDY GROUP

EHA Library, Evangelos Terpos, 4160844

REAL-WORLD OCULAR MONITORING AND SAFETY OF BELANTAMAB MAFODOTIN (BELAMAF) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED IN EUROPE AND THE US

EHA Library, Fredrik Schjesvold, 4160846

UNDERSTANDING THE BIOLOGY OF FRAILTY IN MYELOMA: JOINING SERUM PROTEOMICS WITH CLINICAL DATA USING MACHINE LEARNING

EHA Library, Adam Jones, 4160847

IMPACT OF 1Q GAIN AND AMPLIFICATION IN PATIENTS TREATED WITH ANTI-CD38 MONOCLONAL ANTIBODIES. REAL WORLD DATA FROM A SINGLE CENTER IN SPAIN.

EHA Library, María Sánchez Tabernero, 4160848

CORRELATION ANALYSIS BETWEEN INTENSIVE FOLLOW-UP MANAGEMENT STRATEGIES AND PROGNOSIS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Junling Zhuang, 4160849

MINIMAL CLONAL PLASMA CELL CONTAMINATION OF PERIPHERAL STEM CELL GRAFTS HAVE AN ADVERSE PROGNOSTIC IMPACT IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS TRANSPLANTATION

EHA Library, Jin Lu, 4160851

LONG-TERM FOLLOW-UP OF TANDEM AUTOLOGOUS VERSUS AUTOLOGOUS/ REDUCED-INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION FROM RELATED OR UNRELATED DONORS IN FIRST-LINE THERAPY IN 149 PATIENTS WITH HIGH-RISK MYELOMA

EHA Library, Song-Yau Wang, 4160852

A REAL-WORLD STUDY OF LENALIDOMIDE REFRACTORY MULTIPLE MYELOMA PATIENTS IN FINLAND: TREATMENT AND OUTCOMES

EHA Library, Marika Waltari, 4160853

HEPATIC RESPONSE DYNAMICS IN NEWLY DIAGNOSED LIGHT-CHAIN AMYLOIDOSIS PATIENTS

EHA Library, Chengyang Xu, 4160854

EARLY RELAPSE AND HIGH-RISK FUNCTIONAL PROFILE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS TREATED FRONTLINE WITH BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD)

EHA Library, Itziar Carro Arostegui, 4160855

INCIDENCE OF INFECTIONS AND MICROBIOLOGICAL PATTERN IN PATIENTS WITH MULTIPLE MYELOMA IN A REAL-WORLD POPULATION IN NORWAY

EHA Library, Juni Songe Paulsen, 4160856

IN-CLASS TRANSITION (ICT) FROM PARENTERAL BORTEZOMIB (V) TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): SUBGROUP ANALYSIS OF US MM-6 BY RACE/ETHNICITY, RENAL FUNCTION, AND AREA INCOME

EHA Library, Ruemu Birhiray, 4160857

OUTCOMES IN PATIENTS (PTS) WITH TRIPLE-CLASS EXPOSED (TCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH REAL-LIFE STANDARD OF CARE (SOC) THERAPIES IN LOCOMMOTION AND MOMMENT FINAL DATA

EHA Library, Katja Weisel, 4160858

IBERDOMIDE AND DEXAMETHASONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Noemi Puig, 4160859

A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF SECONDARY IMMUNODEFICIENCY AND RISK OF INFECTION IN PATIENTS WITH AL AMYLOIDOSIS TREATED WITH DARATUMAMAB-BASED INDUCTION REGIMENS. A MULTICENTER ITALIAN EXPERIENCE

EHA Library, Anna Furlan, 4160860

IMPACT OF CORTICOSTEROIDS ON THE EFFICACY AND TOXICITY OF BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Cristian Gutierrez-Padilla, 4160861

INCIDENCE AND SURVIVAL OF MULTIPLE MYELOMA IN ENGLAND: AN UNSELECTED COHORT STUDY FROM THE UNCOVER STUDY GROUP AND UKMRA FRAILTY GROUP.

EHA Library, Thea Chandler, 4160862

IMPACT OF SALVAGE THERAPY ON OUTCOMES OF PATIENTS WITH FUNCTIONAL HIGH RISK MULTIPLE MYELOMA FROM THE HONEUR FEDERATED DATA NETWORK

EHA Library, Yael Cohen, 4160863

RENAL RESPONSE AND PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT APPLYING VRD AND AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Chengcheng Fu, 4160864

THROMBOPROPHYLAXIS PRESCRIBING PATTERN AND RATES OF THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH MULTIPLE MYELOMA IN THE LARGEST HEALTHCARE SYSTEM IN NEW YORK

EHA Library, Phyu Thin Naing, 4160865

QUALITY OF PATIENT-REPORTED OUTCOME REPORTING IN MULTIPLE MYELOMA RANDOMIZED CONTROLLED TRIALS PROTOCOLS AND PUBLICATIONS ACCORDING TO THE SPIRIT-PRO AND CONSORT-PRO: A SYSTEMATIC REVIEW

EHA Library, Darshi Shah, 4160866

THE EFFICACY AND SAFETY OF DARATUMUMAB-BASED REGIMENS IN THE INITIAL TREATMENT OF AMYLOID LIGHT-CHAIN AMYLOIDOSIS

EHA Library, Kai Ding, 4160867

PHASE 3 DREAMM-10 STUDY DESIGN: BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE AND DEXAMETHASONE VS DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE NEWLY-DIAGNOSED MULTIPLE MYELOMA

EHA Library, Meletios Dimopoulos, 4160868

UNRAVELING THE MYELOFIBROTIC BONE MARROW NICHE: STROMAL AND IMMUNE INTERACTIONS AS POTENTIAL THERAPEUTIC TARGETS

EHA Library, Martina Crysandt, 4160869

SINGLE CELL MULTIOMIC ANALYSIS UNCOVERS MOLECULAR AND CLONAL EVENTS ASSOCIATED WITH RUXOLITINIB TREATMENT RESPONSE IN MYELOFIBROSIS

EHA Library, Sebastiano Rontauroli, 4160870

DECIPHERING BONE MARROW ENDOTHELIAL DYSFUNCTION IN MYELOPROLIFERATIVE NEOPLASMS THROUGH SPATIAL TRANSCRIPTOMICS

EHA Library, Jimena Castorena Rodriguez, 4160871

CHARACTERIZATION OF CD9 AS A NOVEL MARKER FOR DISEASE-PROPAGATING STEM CELLS IN MYELOFIBROSIS

EHA Library, Lara Tavernari, 4160872

THE IMMUNE-MODULATORY FUNCTION OF MEGAKARYOCYTES IN THE HEMATOPOIETIC NICHE OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Huichun Zhan, 4160873

REFINING MPN RISK STRATIFICATION USING AUGMENTED AI-DRIVEN BONE MARROW MORPHOLOGICAL ANALYSIS

EHA Library, Xuezi Hu, 4160874

MED12L: A COMPONENT OF THE MEDIATOR COMPLEX AS A POTENTIAL NOVEL ORCHESTRATOR OF PLATELET DYSFUNCTION IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Matteo Brindisi, 4160875

EMBRYONIC HEMATOPOIETIC STEM AND PROGENITOR CELLS SHOW DIFFERENTIAL SUSCEPTIBILITY TO LEUKEMIC TRANSFORMATION UPON ACQUISITION OF JMML-ASSOCIATED KRASG12D MUTATION

EHA Library, Emanuele Azzoni, 4160876

GERMLINE VARIANTS IN MYELOPROLIFERATIVE NEOPLASMS WITH EARLY ONSET OR FAMILIAL HISTORY

EHA Library, Elisa Rumi, 4160877

APPLICATION OF WHOLE GENOME SEQUENCING IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN

EHA Library, Marina Gaskova, 4160878

TARGETED INHIBITION OF ACTIVATED NEUTROPHIL TRANSMIGRATION AMELIORATES MYELOPROLIFERATIVE NEOPLASM IN MICE

EHA Library, Sarolta Bojtiné Kovács, 4160879

INCB057643, A BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR, HAS NOVEL ROLES IN MYELOID CELL REGULATION AND IMMUNOSUPPRESSIVE TUMOUR ENVIRONMENT REMODELLING IN MYELOFIBROSIS

EHA Library, Hamza Celik, 4160880

TUMOUR NEUTROPHIL DYSFUNCTION IN PRIMARY MYELOFIBROSIS: MITOCHONDRIAL IMPAIRMENT, OXIDATIVE STRESS, AND REDUCED ASCORBIC ACID PRODUCTION SHAPE THE BONE MARROW MICROENVIRONMENT

EHA Library, Enrico La Spina, 4160882

CLINICAL AND GENE EXPRESSION PATTERNS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH LOW-RISK MYELOFIBROSIS ENROLLED IN THE MYELOFIBROSIS AND ESSENTIAL THROMBOCYTHEMIA OBSERVATIONAL STUDY (MOST)

EHA Library, Abdulraheem Yacoub, 4160883

IDENTIFICATION AND VALIDATION OF A NOVEL FERROPTOSIS-RELATED GENE SIGNATURE FOR PREDICTION OF THE PROGNOSIS IN PRIMARY MYELOFIBROSIS : BASED ON SINGLE-CELL ANALYSIS AND MACHINE LEARNING

EHA Library, Jian Huang, 4160884

THE COOPERATION BETWEEN CALRDEL52 AND TP53 MUTATIONS INCREASES THE NUMBER OF IMMATURE HEMATOPOIETIC PROGENITORS AND ENHANCES THROMBOPOIETIN-INDEPENDENT MEGAKARYOPOIESIS

EHA Library, Suzana Benedito, 4160885

ALLELIC POLYMORPHISMS IN KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENES MODULATE THE RISK FOR DEVELOPMENT OF PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Velizar Shivarov, 4160886

THERAPEUTIC STRATEGIES TARGETING SRSF2 AND KIT MUTATIONS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Ken-Hong Lim, 4160887

GLUTAMATE OVERLOAD IN THE MYELOFIBROSIS MICROENVIRONMENT RESHAPES MESENCHYMAL STROMAL CELLS' EPIGENETIC ARCHITECTURE TOWARD SENESCENCE.

EHA Library, Sebastiano Giallongo, 4160888

ANTI-HEMOJUVELIN MONOCLONAL ANTIBODY FURTHER ENHANCES HEMATOLOGIC RESPONSE TO ESA AND/OR LUSPATERCEPT IN MICE

EHA Library, Min Wu, 4160889

NOVEL INSIGHTS INTO THE INNATE IMMUNE LANDSCAPE OF MUTANT CALRETICULIN-DRIVEN MPN

EHA Library, Agnieszka Witalisz-Siepracka, 4160890

PRESENCE OF PERIPHERAL BLASTS PREDICT WORSE CLINICAL OUTCOMES IN PATIENTS WITH POLYCYTHEMIA VERA IRRESPECTIVE OF STANDARD RISK FACTORS

EHA Library, Lucia Masarova, 4160891

SOLUBLE ST2 AS A POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN SYSTEMIC MASTOCYTOSIS

EHA Library, Etnik Sheremeti, 4160892

MOLECULAR DETERMINANTS OF RESISTANCE TO ROPEGINTERFERON ALFA-2B IN PV AND ET

EHA Library, Jihyun Song, 4160893

T CELL MATURATION SHIFT TOWARD A SENESCENT PROFILE AND ENHANCED INHIBITORY SIGNALING VIAREGULATORY T CELLS ARE ASSOCIATED WITH ADVANCED MYELOFIBROSIS

EHA Library, Camila Garcia, 4160894

IDENTIFICATION OF ULTRA HIGH-RISK GENOTYPES FOR PROGRESSION TO BLAST PHASE DISEASE REDEFINES MOLECULAR-BASED STRATIFICATION OF MYELOFIBROSIS

EHA Library, Noushin Farnoud, 4160895

A STUDY TO EVALUATE SINGLE-AGENT SELINEXOR VERSUS PHYSICIAN'S CHOICE IN PARTICIPANTS WITH PREVIOUSLY TREATED MYELOFIBROSIS

EHA Library, Alessandro Lucchesi, 4160896

SAFETY AND EFFICACY OF BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY

EHA Library, Pankit Vachhani, 4160897

CLINICAL AND MOLECULAR CHARACTERISTICS OF MYELOPROLIFERATIVE NEOPLASMS IN THE ADOLESCENTS AND YOUNG ADULTS POPULATION

EHA Library, Songyang Zhao, 4160898

CLINICAL TRAJECTORIES AND GENOMIC HETEROGENEITY IN AYA VERSUS NON-AYA ESSENTIAL THROMBOCYTHEMIA: A COMPARATIVE STUDY INTEGRATING CLINICAL PROFILES, OUTCOMES, AND NEXT-GENERATION SEQUENCING

EHA Library, Jian Huang, 4160899

DYNAMIC ELEVATIONS OF EARLY-STAGE MYELOID-DERIVED SUPPRESSOR CELLS PREDICT LEUKEMIC TRANSFORMATION IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOTILNIB: A REAL-WORLD, PROSPECTIVE, LONGITUDINAL STUDY

EHA Library, Jian Huang, 4160900

DECODING THE MYELOPROLIFERATIVE NEOPLASM CONTINUUM: A MACHINE LEARNING APPROACH TO DISEASE EVOLUTION AND PROGNOSTIC STRATIFICATION

EHA Library, Yu-Hung Wang, 4160901

REAL-WORLD EFFECTIVENSS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS WHO HAVE THROMBOCYTOPENIA AND ANEMIA

EHA Library, Raajit K Rampal, 4160902

EXPLORATORY ANALYSIS OF GECACITINIB IN RUXOLITINIB-INTOLERANT MYELOFIBROSIS PATIENTS: IMPACT OF BASELINE ANEMIA AND PRIOR RUXOLITINIB TREATMENT DURATION ON RESPONSE TO GECACITINIB

EHA Library, Yi Zhang, 4160903

IMPACT OF DUAL SPLEEN RESPONSE AND TRANSFUSION INDEPENDENCE ON SURVIVAL IN JAK INHIBITOR-NAIVE PATIENTS WITH MYELOFIBROSIS AND ANEMIA TREATED WITH MOMELOTINIB: A SUBGROUP ANALYSIS OF SIMPLIFY-1

EHA Library, Francesca Palandri, 4160904

A PHASE I/II, OPEN-LABEL, MULTI-CENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF RUXOLITINIB AND CPX-351 IN COMBINATION FOR THE TREATMENT OF ADVANCED PHASE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Shivani Handa, 4160905

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH PRIMARY AND SECONDARY MYELOFIBROSIS TREATED WITH RUXOLITINIB: JUMP STUDY

EHA Library, Haifa Kathrin Al-Ali, 4160906

A PHASE 1/2A TRIAL OF PXS-5505, A NOVEL PAN-LYSYL OXIDASE INHIBITOR, IN PATIENTS WITH ADVANCED MYELOFIBROSIS

EHA Library, Anne-Marie Watson, 4160907

COMBINED CKIT D816V LIQUID BIOPSY AND HαT GENOTYPING: A NON-INVASIVE DIAGNOSTIC WORK-UP FOR THE SENSITIVE AND SPECIFIC DETECTION OF SYSTEMIC MASTOCYTOSIS

EHA Library, Daniel Koch, 4160908

DEVELOPMENT AND VALIDATIONTION OF A MODEL FOR PREDICTING LEUKEMIC TRANSFORMATION IN MYELOFIBROSIS PATIENTS A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Jian Huang, 4160909

HEALTH-RELATED QUALITY OF LIFE BENEFITS OF FRONTLINE PONATINIB PLUS BLINATUMOMAB IN ADULT PATIENTS WITH PH+ ACUTE LYMPHOBLASTIC LEUKEMIA. PRELIMINARY ANALYSIS OF THE GIMEMA ALL2820 TRIAL

EHA Library, Laura Cannella, 4161355

EXPLORING THE BELGIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) POPULATION THROUGH AI AND DIGITAL TECHNOLOGIES: INSIGHTS FROM THE BE-CLLEAR STUDY

EHA Library, Ann Debecker, 4161400